The study aimed to investigate the effects of AMPK inhibition on reactive oxygen species (ROS)-nuclear factor κB (NFκB) signaling and endotoxemia-induced liver injury. The gene discussed is PRKAA1; the disease is serum lipopolysaccharide activity.